Workflow
Merit Medical(MMSI) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
1 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others: The forward-looking statements contained in this release are based on Merit management's current expectations and assumptions regarding future events or outcomes. If underlying expectations or assumption ...
Tempus Ai,Inc.(TEM) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
Tempus AI, Inc. Investor Presentation Q4 2025 and Full Year 2025 FEBRUARY 2026 Disclaimer This presentation contains forward-looking statements that reflect Tempus AI, Inc.'s (the "Company" or "Tempus") current expectations and projections with respect to, among other things, its financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include all statements that are not historical facts. Such forward-looking statements are subject to various ...
Day One Biopharmaceuticals pany(DAWN) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
FEBRUARY 2026 Fourth Quarter & Full-Year 2025 Financial Results & Corporate Progress In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this presentation, and although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted ...
Axon(AXON) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
INVESTOR PRESENTATION VIEW REPORT F E B R U A R Y 2026 I N V E S T O R D E C K Q 4 2 0 2 5 OVERVIEW OUR ECOSYSTEM MARKET OPPORTUNITY FINANCIALS APPENDIX 2 SAFE-HARBOR STATEMENT Forward-looking statements in this letter include, without limitation, statements regarding: proposed products and services and related development efforts and activities; expectations about the market for our current and future products and services, including statements related to our user base and customer profiles; strategies and ...
CareDx(CDNA) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this presentation, including statements regarding the future financial position of CareDx®, Inc. (together with its subsidiaries, "CareDx" or the "Company"), including financial targets and ...
Jazz Pharmaceuticals(JAZZ) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
February 24, 2026 2025 Fourth Quarter and Full Year Financial Results Redefining Possibilities in Rare Disease Transforming Lives. Redefining Possibilities. Caution Concerning Forward-Looking Statements This presentation contains forward-looking statements, including, but not limited to, statements related to: the Company's growth prospects and future financial and operating results, including the Company's 2026 financial guidance and the Company's expectations related thereto; anticipated multiple near-ter ...
TransMedics(TMDX) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
TransMedics Q4 2025 Performance Highlights February 24, 2026 2 TMDX Q4 2025 Performance – Key Highlights Product Revenue $100.4M 33.9% Y/Y Growth 14.5% Q/Q Growth 1 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements address various matters, including, among other things, future results and events, including financial guidance and projected estimates, and other statements that are predictive in nature. Investors are cau ...
Revolve(RVLV) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
1 Note on Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would," or similar expressions and the negatives of those terms. Forward-loo ...
Marqeta(MQ) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
Marqeta Earnings Supplement February 24, 2026 Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements expressed or implied in this presentation include, but are not limited to, statements relating to Marqeta's quarterly and annual guidance. Actual results may differ materially from the expectations contained in these statements due to risks and uncertai ...
Alphatec (ATEC) - 2025 Q4 - Earnings Call Presentation
2026-02-24 21:30
Q4 2025 FINANCIAL RESULTS PAT MILES, CHAIRMAN & CEO | TODD KNING, EVP & CFO | FEBRUARY 24, 2026 FORWARD-LOOKING STATEMENTS This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking stateme ...